Percutaneous transluminal angioplasty in severe diabetic foot ischemia: outcomes and prognostic factors

被引:27
|
作者
Jacqueminet, S [1 ]
Hartemann-Heurtier, A
Izzillo, R
Cluzel, P
Golmard, JL
Van, GH
Koskas, F
Grimaldi, A
机构
[1] Hop La Pitie Salpetriere, Diabet & Metab Dis Unit, Serv Diabetol & Metab, F-75651 Paris, France
[2] Hop La Pitie Salpetriere, Dept Radiol Intervent, F-75651 Paris, France
[3] Univ Paris 06, Serv Biostat, Paris, France
[4] Hop La Pitie Salpetriere, Dept Chirurg Vasc, F-75651 Paris, France
关键词
diabetic foot ulcer; peripheral arterial disease; percutaneous transluminal angioplasty;
D O I
10.1016/S1262-3636(07)70206-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To evaluate the outcomes of severe ischemic diabetic foot ulcers for which percutaneous transluminal angioplasty (PTA) was considered as the first-line vascular procedure. Factors associated with successful PTA were sought. Research design and methods: In 32 consecutive diabetic patients with foot ulcers and severe limb ischemia, PTA was performed if feasible; if not, primary bypass grafting was done when feasible. All patients were followed until healing or for at least one year. Patients with worsening ulcers after PTA underwent bypass grafting. Clinical and angiographic factors influencing outcomes after PTA were sought by univariate and multivariate analysis. Results: PTA was done in 25 of the 32 (78%) patients, and considered clinically successful in 13 (52%). After 1 year, the healing rate was 70% and the limb salvage rate 90%. Successful PTA was significantly associated with a higher post-PTA transcutaneous oxygen pressure (P = 0.03) and presence of at least one patent pedal vessel (P = 0.03) in the univariate analysis; only a patent pedal vessel was significant in the multivariate analysis. Conclusion: Primary PTA in diabetic patients with severe ischemic foot ulcers provides similar outcomes to usual results obtained in severe ischemia in absence of diabetes. The presence of one patent pedal vessel on arteriography before PTA is the best prognostic factor.
引用
收藏
页码:370 / 375
页数:6
相关论文
共 50 条
  • [1] Percutaneous Transluminal Angioplasty in the Treatment of Diabetic foot
    Liu Qingwen
    CEREBROVASCULAR DISEASES, 2017, 44 : 27 - 27
  • [2] Diabetic Foot Versus Nondiabetic Foot: Are There Different Outcomes Following Percutaneous Transluminal Angioplasty in Patients with Critical Limb Ischemia?
    Rha, Seung-Woon
    Park, Ji Young
    Poddar, Kanhaiya L.
    Ramasamy, Sureshkumar
    Wang, Lin
    Choi, Byoung Geol
    Choi, Cheol Ung
    Park, Chang Gyu
    Seo, Hong Seog
    Oh, Dong Joo
    CIRCULATION, 2010, 122 (02) : E341 - E341
  • [3] Diabetic Foot Versus Nondiabetic Foot: Are There Different Outcomes Following Percutaneous Transluminal Angioplasty in Patients with Critical Limb Ischemia?
    Rha, Seung Woon
    Park, Ji Young
    Poddar, Kanhaiya L.
    Ramasamy, Sureshkumar
    Wang, Lin
    Choi, Byoung Geol
    Kim, Ji Bak
    Shin, Seung Yong
    Choi, Cheol Ung
    Lim, Hong Euy
    Kim, Jin Won
    Kim, Eung Ju
    Park, Chang Gyu
    Seo, Hong Seog
    Oh, Dong Joo
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (9A): : 22B - 22B
  • [4] Salvage Percutaneous Transluminal Angioplasty of the Superficial Femoral Artery in the Diabetic Foot With Deteriorating Limb Ischemia
    Bang, Chi Young
    Jeong, Chanho
    Lee, Seung Ho
    Sung, Kunyong
    Lee, Bong-Ki
    Lee, Sang-Yeul
    WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE, 2023, 35 (08): : E261 - E264
  • [5] Evaluation of the effect of percutaneous transluminal angioplasty in patients with the diabetic foot
    Wosková, V
    Jirkovská, A
    Peregrin, J
    Skibová, J
    DIABETOLOGIA, 1998, 41 : A278 - A278
  • [6] Percutaneous transluminal angioplasty as first treatment of ischemic diabetic foot
    Danzi, Gian Battista
    Ferraresi, Roberto
    Sozzi, Fabiola
    Ferlini, Marco
    Pomidossi, Guido
    Caravaggi, Carlo
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 240M - 240M
  • [7] Outcomes and prognostic factors of peroneal artery transluminal angioplasty in critical limb ischemia
    Gargiulo, M.
    Ceccacci, T.
    Faggioli, G. L.
    Freyrie, A.
    Maioli, F.
    Giovanetti, F.
    Bessone, M.
    Stella, A.
    JOURNAL OF ENDOVASCULAR THERAPY, 2007, 14 : I10 - I11
  • [8] Sulodexide as Adjunctive Therapy in Diabetic Foot Patients With Critical Limb Ischemia Treated With Percutaneous Transluminal Angioplasty
    Piaggesi, Alberto
    Abbruzzese, Lorenza
    Mattaliano, Chiara
    Bargellini, Irene
    Cicorelli, Antonello
    Iacopi, Elisabetta
    Lunardi, Alessandro
    Coppelli, Alberto
    Goretti, Chiara
    Cioni, Roberto
    INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS, 2014, 13 (02): : 103 - 109
  • [9] Prospective trial of percutaneous transluminal angioplasty (PTA) as a primary treatment in diabetic foot ulcer with severe ischaemia.
    Hartemann-Heurtier, A
    Jacqueminet, S
    Cluzel, P
    Van, GH
    Izzillo, R
    Simon, D
    Grimaldi, A
    DIABETOLOGIA, 2003, 46 : A5 - A5
  • [10] Comparison of the effect of stem cell therapy and percutaneous transluminal angioplasty on diabetic foot disease in patients with critical limb ischemia
    Dubsky, Michal
    Jirkovska, Alexandra
    Bem, Robert
    Fejfarova, Vladimira
    Pagacova, Libuse
    Nemcova, Andrea
    Sixta, Bedrich
    Chlupac, Jaroslav
    Peregrin, Jan H.
    Sykova, Eva
    Jude, Edward B.
    CYTOTHERAPY, 2014, 16 (12) : 1733 - 1738